Drug Disposition Classification Systems in Discovery and Development: A Comparative Review of the BDDCS, ECCS and ECCCS Concepts

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Pharmaceutical Research

• Publication date

  2016-07-20

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11095-016-2001-6PMID 27439505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New IVIVE method for the prediction of total human clearance and relative elimination pathway contributions from in vitro hepatocyte and microsome data.

  2016cited by this paper
• BDDCS, the Rule of 5 and drugability.

  2016cited by this paper
• Predicting the extent of metabolism using in vitro permeability rate measurements and in silico permeability rate predictions.

  2015cited by this paper
• The extended clearance model and its use for the interpretation of hepatobiliary elimination data

  2015cited by this paper
• Application of the extended clearance concept classification system (ECCCS) to predict the victim drug-drug interaction potential of statins

  2015cited by this paper
• BDDCS Predictions, Self-Correcting Aspects of BDDCS Assignments, BDDCS Assignment Corrections, and Classification for more than 175 Additional Drugs

  2015cited by this paper
• Quantitative Structure-Pharmacokinetic Relationships for the Prediction of Renal Clearance in Humans

  2015cited by this paper
• Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS)

  2015cited by this paper
• In vitro-in vivo extrapolation method to predict human renal clearance of drugs.

  2014cited by this paper
• Predicting when Biliary Excretion of Parent Drug is a Major Route of Elimination in Humans

  2014cited by this paper
• Clearance mechanism assignment and total clearance prediction in human based upon in silico models.

  2014cited by this paper
• The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development.

  2013cited by this paper
• Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.

  2013cited by this paper
• Predicting human hepatic clearance from in vitro drug metabolism and transport data: a scientific and pharmaceutical perspective for assessing drug–drug interactions

  2012cited by this paper
• Novel In Vitro-In Vivo Extrapolation (IVIVE) Method to Predict Hepatic Organ Clearance in Rat

  2012cited by this paper
• BDDCS class prediction for new molecular entities.

  2012cited by this paper
• The BCS, BDDCS, and Regulatory Guidances

  2011cited by this paper
• BDDCS Applied to Over 900 Drugs

  2011cited by this paper
• In Vitro?In Vivo Correlation (IVIVC): A Strategic Tool in Drug Development

  2011cited by this paper
• The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs

  2009cited by this paper
• Physiologically based pharmacokinetics (PBPK)

  2009cited by this paper
• Physicochemical determinants of human renal clearance.

  2009cited by this paper
• The Use of BDDCS in Classifying the Permeability of Marketed Drugs

  2008cited by this paper
• The Role of Permeability in Drug ADME/PK, Interactions and Toxicity—Presentation of a Permeability-Based Classification System (PCS) for Prediction of ADME/PK in Humans

  2008cited by this paper
• SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin

  2006cited by this paper
• Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System

  2004cited by this paper
• Clinical Pharmacokinetics of Atorvastatin

  2003cited by this paper
• Shapes of membrane permeability-lipophilicity curves: extension of theoretical models with an aqueous pore pathway.

  1998cited by this paper
• Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight.

  1998cited by this paper
• A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

  1995cited by this paper

• Biopharmaceutics Classification System (BCS) An overview

  2025cites this paper
• Improving In Vitro–In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound Molecules

  2024cites this paper
• Effect of food on oral pharmacokinetics of edaravone coamorphous dispersion containing bile salts as coformers- part II.

  2024cites this paper
• A Window for Enhanced Oral Delivery of Therapeutics via Lipid Nanoparticles

  2024cites this paper
• Simplifying the Extended Clearance Concept Classification System (EC3S) to Guide Clearance Prediction in Drug Discovery

  2023cites this paper
• Biowaiver based on biopharmaceutics classification system: Considerations and requirements

  2023cites this paper
• Comparator product issues for biowaiver implementation: the case of Fluconazole

  2022cites this paper
• Investigating the uncertainty of prediction accuracy for the application of physiologically based pharmacokinetic models to animal-free risk assessment of cosmetic ingredients.

  2022cites this paper
• IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making

  2022cites this paper
• Meeting report of the first European biotransformation workshop

  2021cites this paper
• The science of pharmacokinetics: an overview and applications

  2021cites this paper
• Primary Human Hepatocyte Spheroids as an In Vitro Tool for Investigating Drug Compounds with Low Hepatic Clearance

  2021cites this paper
• Prediction of Drug Clearance from Enzyme and Transporter Kinetics.

  2021cites this paper
• The Extended Clearance Model

  2021cites this paper
• Novel Bruton’s Tyrosine Kinase inhibitor remibrutinib: Drug‐drug interaction potential as a victim of CYP3A4 inhibitors based on clinical data and PBPK modeling

  2021cites this paper
• In silico prediction of the full United Nations Globally Harmonized System eye irritation categories of liquid chemicals by IATA-like bottom-up approach of random forest method

  2021cites this paper
• Comparative analysis of biopharmaceutic classification system (BCS) based biowaiver protocols to validate equivalence of a multisource product

  2020cites this paper
• Use of imaging to assess the activity of hepatic transporters

  2020cites this paper
• A novel strategy for prediction of human plasma protein binding using machine learning techniques

  2020cites this paper
• Human Efflux Transporters in Drug Disposition : in vitro Transport of Glucuronide Metabolites

  2019cites this paper
• Examining P‐gp efflux kinetics guided by the BDDCS ‐ Rational selection of in vitro assay designs and mathematical models

  2019cites this paper
• Cytotoxic 2‐(2′‐Hydroxyphenyl)benzothiazolylquinoline Analogues and their In Vitro Screening through Developmental Assays †

  2019cites this paper
• The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines.

  2019cites this paper
• The potential protein-mediated hepatic uptake: discussion on the molecular interactions between albumin and the hepatocyte cell surface and their implications for the in vitro-to-in vivo extrapolations of hepatic clearance of drugs

  2019cites this paper
• Improving Prediction of Metabolic Clearance Using Quantitative Extrapolation of Results Obtained From Human Hepatic Micropatterned Cocultures Model and by Considering the Impact of Albumin Binding.

  2018cites this paper
• Dissolution Profile Consideration in Pharmaceutical Product Development

  2018influential citation
• Clearance in Drug Design.

  2018cites this paper
• Structural and functional pharmacokinetic analogs for physiologically based pharmacokinetic (PBPK) model evaluation

  2018cites this paper
• Advancing internal exposure and physiologically-based toxicokinetic modeling for 21st-century risk assessments

  2018cites this paper
• Models and Approaches Describing the Metabolism, Transport, and Toxicity of Drugs Administered by the Ocular Route

  2018cites this paper
• Comparative Oral Drug Classification Systems: Acetazolamide, Azithromycin, Clopidogrel, and Efavirenz Case Studies.

  2018cites this paper
• Evaluating In Vitro-In Vivo Extrapolation of Toxicokinetics

  2018influential citation
• Rapid experimental measurements of physicochemical properties to inform models and testing.

  2018cites this paper
• Simultaneous Assessment of Clearance, Metabolism, Induction, and Drug-Drug Interaction Potential Using a Long-Term In Vitro Liver Model for a Novel Hepatitis B Virus Inhibitor

  2018cites this paper
• Current In Vitro Methods to Determine Hepatic Kpuu: A Comparison of Their Usefulness and Limitations.

  2017cites this paper
• Identification of cryptolepine metabolites in rat and human hepatocytes and metabolism and pharmacokinetics of cryptolepine in Sprague Dawley rats

  2017cites this paper
• Assessing the Risk of Drug-Induced Cholestasis Using Unbound Intrahepatic Concentrations

  2017influential citation